Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

A cautionary note on the use of unsupervised machine learning algorithms to characterise malaria parasite population structure from genetic distance matrices.

Watson JA. et al, (2020), PLoS genetics, 16

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.

RECOVERY Collaborative Group None. et al, (2020), The New England journal of medicine

COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology

White NJ. et al, (2020), PLOS Medicine, 17, e1003252 - e1003252

Advances and Roadblocks in the Treatment of Malaria.

Hanboonkunupakarn B. and White NJ., (2020), British journal of clinical pharmacology

Concentration-dependent mortality of chloroquine in overdose

Watson JA. et al, (2020), eLife, 9

Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study

Imwong M. et al, (2020), The Lancet Infectious Diseases

Non-adherence in non-inferiority trials: pitfalls and recommendations.

Mo Y. et al, (2020), BMJ (Clinical research ed.), 370

Estimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis

Commons RJ. et al, (2020), The American Journal of Tropical Medicine and Hygiene

Bacteremia in adults with severe malaria.

White NJ., (2020), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.

Saito M. et al, (2020), BMC medicine, 18

COVID-19 and risks to the supply and quality of tests, drugs, and vaccines.

Newton PN. et al, (2020), The Lancet. Global health, 8, e754 - e755

Primaquine for Plasmodium vivax malaria treatment – Authors' reply

Price RN. et al, (2020), The Lancet, 395, 1972 - 1972

Utility of Plasmodium falciparum DNA from rapid diagnostic test kits for molecular analysis and whole genome amplification.

Srisutham S. et al, (2020), Malaria journal, 19

Forging a British world of trade: culture, ethnicity, and market in the Empire-Commonwealth, 1880-1975

White NJ., (2020), ECONOMIC HISTORY REVIEW, 73, 597 - 599

Safety, Pharmacokinetics, and Mosquito-Lethal Effects of Ivermectin in Combination With Dihydroartemisinin-Piperaquine and Primaquine in Healthy Adult Thai Subjects.

Kobylinski KC. et al, (2020), Clinical pharmacology and therapeutics, 107, 1221 - 1230

Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis.

Saito M. et al, (2020), The Lancet. Infectious diseases

Cardiovascular safety and population pharmacokinetic properties of piperaquine in African patients with uncomplicated falciparum malaria - a pooled multicentre analysis.

Wattanakul T. et al, (2020), Antimicrobial agents and chemotherapy

Reduced Cardiac Index Reserve and Hypovolemia in Severe Falciparum Malaria

Kingston HWF. et al, (2020), The Journal of Infectious Diseases, 221, 1518 - 1527

Survival of Burkholderia pseudomallei and Pathogenic Leptospira in Cola, Beer, Energy Drinks, and Sports Drinks.

Wuthiekanun V. et al, (2020), The American journal of tropical medicine and hygiene

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial

van der Pluijm RW. et al, (2020), The Lancet, 395, 1345 - 1360

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?